ʻO ka Novonorm kahi lāʻau lapaʻau i heluʻia e ka hui o nā lāʻau lapaʻau me ka hopena hypoglycemic ikaika (hypoglycemic).
Kahi pūnaʻina o kēia lāʻau lapaʻau me kahi mea i kapa ʻia ʻo repaglinide.
Kālila ka hana o ka hana i ka mea hiki ke kāohi i nā kanaleka pā hilinaʻi ATP i loaʻa i nā membran beta cells. Ma muli o kēia kaʻina, ua hōʻole ka membrane a wehe ʻia nā honu o ka calcium, a ke hoʻokomo nei ka nuʻu o nā puna kalaka i loko o ka beta beta, e hoʻomaikaʻi nui ana, ma ka hopena ke hoʻoulu nei i ka mea huna o ka hormone pancreas e nā cell beta.
Hāʻawi ka lāʻau lapaʻau i ka nīnau i ka normalization o ke kōhi koko, ma muli o ka hapa hapa o ka ola. He mea nui ia e hoʻomaopopo e hiki i ka poʻe ke hoʻokō i ka meaʻaiʻai ʻole wale inā he lawe lākou i Novonorm. No laila ua hoʻohana ʻia no ia?
Nā hana hana i ka hana
E hoʻomaopopo pono he lāʻau lapaʻau ka Novonorm e hoʻemi ana i ke kahe koko, kahi i manaʻo ʻia no ka hoʻoponopono waha. He hana pōkole.
Ma ke kānāwai, hoʻomaʻamaʻa koke ia i ka loaʻa ʻana o ke kō. No laila, ke hoʻoikaika nei i ka hana o ka hormone o ka pancreas. Hoʻohui kēia lāʻau lāʻau ma ka membrane o nā p-cell me kahi ʻōmole receptor kūikawā no kēia lāʻau.
Nā papale Novonorm 1 mg
Ma hope aku, ʻo ia kahi mea e alakaʻi i ka pani koke ʻana o nā pā paʻuhū a me ke kūpaʻa o ka ATP a me ka depolarization o nā membrane cell. Eia kekahi, kōkua iā ia i ka wehe ʻana o nā alima kalaiwa. ʻO ke kao loa o ka calcium ma loko o ka p-cell e hoʻoikaika i ka hoʻokuʻu i ka insulin.
I ka poʻe e ʻeha nei i kēlā maʻi endocrine e like me ka diabetes mellitus, ka hapa nui o ke ʻano lua, ʻike ʻia kahi ʻano insulinotropic i loko o ka iwakāluakūmālima mau minuke mai ka manawa o ka lawelawe waha. ʻO kēia ka mea e hōʻoia ai i ka hoʻemi ʻana i nā glucose koko i ka wā holoʻokoʻa o ka ʻai ʻana.
Eia kekahi, hāwau koke nā ʻike o ka repaglinide i ke koko a i loko o nā hola he ʻehā ma hope o ke komo pololei i loko o ke koko o nā poʻe maʻi me ka maʻi type 2, ke kāʻei ʻia kahi hōʻemi haʻahaʻa o ka lāʻau.
Nā hōʻailona no ka hoʻohana ʻana
Naʻi maʻi maʻi
Hoʻohana ʻia ka Novonorm e mālama i ka poʻe me ka diabetes mellitus type 2 (non-insulin-dependence mellitus) inā ʻaʻole i loaʻa nā hopena i manaʻo ʻia e pili ana i ka kaohi ʻana o ke kōʻai koko me ka hoʻohana ʻana i kahi meaʻai kūikawā a me nā haʻuki.
Eia kekahi, ʻike hoʻolako ʻia ka lāʻau lapaʻau i ka nīnau a Metformin a i ʻole thiazolidinediones ka mea i hoʻohana ʻia i ka poʻe no ka mea mālama ʻia me ka lāʻau hoʻokahi. ʻO ka lawe ʻana i kēia lāʻau lapaʻau e hoʻomaka ʻia ma ke ʻano he hana hou no ka pono kūpono a me ka hoʻokaʻawale ʻana i nā mea pono a kūpono pono ʻole.
No ka hoʻoluhi kaumaha
E like me ka mea i hōʻike mua ʻia, hoʻoulu ʻia ʻo Novonorm i ka hana o ka hormone pancreatic.Eia naʻe, ʻo ka wikiwiki o ka hana he lāʻau lapaʻau pōkole.
Ua hōʻike kēia ma ka wikiwiki koke ka hopena - i loko o 30 mau minuke ma hope o ka hoʻokele pololei. Ua hoʻopau loa ʻia ia ma hope o 4 mau hola.
Ua kuhikuhi ʻia ʻo Novonorm no ka mālama ʻana i ka maʻi maʻi 2. ^ E Ha yM. He kūpono ia i nā meaʻai diika ʻole, me ka hoʻomaʻamaʻa ʻana i mea paona.
Hoʻohana wale ʻia ka lāʻau lapaʻau me kēia lāʻau lapaʻau. Akā, i waena o nā mea ʻē aʻe, hiki iā ʻoe ke hoʻohui pū me ia me Metformin a me nā mea hana ʻē aʻe, ʻo ka hana a ke kumu i makemake ai e hoʻohiolo i ke kōpaʻa koko i loko o ka plasma.
Ma ke kānāwai, loaʻa kēia lāʻau lapaʻau i ke ʻano o nā papa. Pono lākou e hele ma mua o ka ʻai pololei ʻana. ʻO ka ʻōlelo aʻo i hoʻopili ʻia e hōʻike ana i ka manawa manawa i makemake ʻia e hoʻohana i ka huina he 16 mau minuke ma mua o kahi pāʻina.
I nā huaʻōlelo ʻē aʻe, pono e inu ʻa ka papa maʻa ma mua o ka hapalua hola ma mua o ka ʻai, a i ʻole ma mua o kēlā.
Ua ʻōlelo nā poʻe hōʻike, ʻo ka manawa maikaʻi loa e lawe i ka lāʻau lapaʻau he 15 mau minuke ma mua o ka papaʻaina.
Ke lawe ʻia nei ka koho o kahi dosage kūpono ʻole. Pono ka liʻiliʻi ʻāpana mua o Novonorm e liʻiliʻi. Ma ke kānāwai, ʻōlelo nā kauka i ka hoʻomaka ʻana me ka 0.5 a i ʻole 1 mg.
I ka wā o ka papa hana, pono ʻoe e hoʻopaʻa mau i ke kōʻai koko. Mālama kēia iā ʻoe e loiloi i ka pane ʻana o ke kino i kēia lāʻau lapaʻau. E like me kāu e ʻike ai, pono e hoʻokō ʻia ka hoʻoponopono ʻana o Novonorm ma kahi o hoʻokahi pule. I kekahi mau manawa, lawa a ʻelua i ka malama.
ʻOi aku ka manawa o ka manawa a me ka nānā ʻana ke koho ʻana o nā dosages i hui pū me nā ʻano lāʻau like ʻole e hoʻemi ana i ke kiʻekiʻe o ke kō i loko o ke kino.
Ma kēia hihia, pono e wehewehe ke kauka i kāna mea maʻi i ka mea e hana ai i ka wā a ia e ʻae iā ia iho i kahi kīʻai a i ʻole, ʻo ia hoʻi, e hele ana i kekahi o nā kī he nui.
No laila, i kēlā kūlana, pono e loli ka huli ʻana i ka papa hana no ka lawe ʻana iā Novonorm.
Nā inoaʻikepili o Novonorm
I kēia manawa, ʻike ʻia kekahi mau analogues ikaika o ka lāʻau i ka nīnau. ʻO kēia ka: Insvada (Switzerland / United Kingdom), Repaglinid (India), Repodiab (Slovenia).
Uila
Hoʻololi ia kona kumukūʻai mai 400 a 600 rubles.
Hoike Mai
ʻO kaʻoiaʻiʻo, ʻokoʻa nā loiloi. Wahi a kekahi ua kōkua ʻo Novonorm iā lākou e hoʻōla i ke koko koko, a ua ʻae nō hoʻi e hoʻemi lākou i ka paona.
A ʻo kahi mea ʻē aʻe, haʻi lākou ʻaʻole i kōkua ka lāʻau lapaʻau iā lākou e hū ai i ka momona.
Nā Hoʻohui
ʻAʻole hiki ke hoʻohana ʻia ka lāʻau lapaʻau no nā maʻi a me nā kūlana o ke kino, e like me:
- maʻi mellitus type 1;
- ketoacidosis;
- maʻiʻeleʻele coma a me ka precoma;
- nā ʻano maʻi āpau o ke ʻano maʻi kolohe e pono ai ka hana kaʻa koke;
- kekahi mau pilikia pathological e koi ai i ka hoʻomehana insulin;
- ʻaihua;
- wā hōʻeha;
- hoʻopilikia koʻikoʻi ma muli o ka paʻi ʻana a me ka ʻōpala;
- ka manawa like me ka gemfibrozil;
- ka heleʻana o hypersensitivity o ka hana ikaika o ka lāʻau a i ʻole nā mea hou aʻe e hana ʻia ana i ka mana.
ʻŌpū a me ka umauma
I kēia manawa, ʻaʻole ʻike ʻia e pili ana i ka hopena o ka lāʻau lapaʻau i ka nīnau ʻana i ke kino o nā wahine hānau i kahi keiki. No kēia kumu, ʻaʻole pono e lawe ʻia ʻo Novonorm i ka wā o ka wā hāpai a me ka lactation.
Nā hopena hopena
ʻO ka hopena ākea ka hopena maʻamau o kēia lāʻau lapaʻau ka hoʻemi haʻahaʻa o ke kō koko.
ʻO ke alapine o kēlā mau hana e kū pololei pono ʻia, e like me ka wā e hoʻohana ai i nā lāʻau lapaʻau ʻē aʻe, ma nā mea kū hoʻokahi. Hoʻopili kēia i ka hopena o ka lāʻau lapaʻau, ka hana kino, a me nā kūlana luhi.
Hoʻomaʻamaʻa pinepine, nā mea maʻi o ka endocrinologists i nā hopena ʻaoʻao e like me:
- kahi hapai oi i ke kō koko;
- haʻi leo hypoglycemic;
- ʻʻAla
- hyperhidrosis;
- e haʻalulu ana ma nā ʻoi loa a me nā haʻahaʻa haʻahaʻa;
- ka pololi ʻaʻole hele a hele a ma hope iho o ka ʻai ʻana;
- ʻike ʻole i ka nānā;
- ʻeha a hōʻeha ʻole i ka ʻōpū;
- holo pōpilikia e ukali ana;
- constipation
- nā ninia
- hana aho pili ole;
- kūlū, i hōʻike ʻia e ka minamina, ʻulaʻula a ka ʻula a me ka ʻihi.
Ke noi no nā keiki
E like me nā wahine hāpai, ʻaʻohe hana noiʻi kūikawā i nā maʻi ma lalo o ka ʻumikumamāwalu makahiki. No kēia kumu, ʻaʻohe pono e hāʻawi iā Novonorm i nā keiki.
Nā wikiō pili
E pili ana i nā lāʻau lapaʻau hoʻohiolo koko no ke ʻano maʻi type 2 i kahi wikiō:
Mai kēia 'atikala, hiki iā mākou ke hoʻomaopopo iā Novonorm kahi lāʻau lapaʻau maikaʻi i hoʻohana' ia ʻaʻole wale no ka hoʻohālikelike 'ana i ke kōpaʻa gula, akā e ho'ēmi i nā paona keu.
Akā naʻe, ʻaʻole ʻoe e lawe i kāu iho ma luna o ka ʻae ʻole o kāu kauka. ʻO kēia ma muli o kahi nui o nā contraindications a me nā hopena hopena.
